# China NMPA Drug Inspection - Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. - Ibuprofen suspension

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shanghai-johnson-johnson-pharmaceutical-co-ltd/17e7d4ea-4ab9-4eaf-987a-23073e3157d0/
Source feed: China

> China NMPA drug inspection for Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Ibuprofen suspension. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Shanghai Johnson & Johnson Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Ibuprofen suspension
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/shanghai-johnson-johnson-pharmaceutical-co-ltd/9a924e53-b031-4987-b0e4-6d45494d6e61/